Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Catholic Archbishops Will Discuss Denying Biden Communion In June

Joe Biden's stance on abortion has caused certain Catholic…
Read more

Abortion Advocates Angry Over Roe V. Wade Challenge

Those in support of abortion have been angry to the recent…
Read more

More Evidence Found for Election Fraud

Over six months after the election, "explosive" evidence…
Read more